Parnax Lab Ltd
₹0.00▲ +0.00 (+0.00%)
506128·NSE·Healthcare
Market Cap
155.06 Cr
PE Ratio
13.44
Volume
—
Day High - Low
—
52W High-Low
144.95 - 108.03
₹0.00▲ +0.00 (+0.00%)
Market Cap155.06 Cr
PE Ratio13.44
Volume—
Day High - Low—
52W High-Low144.95 - 108.03
Parnax Lab Ltd (506128): company summary
Parnax Lab Ltd (506128) is a micro-cap Healthcare company valued at ₹155 crore operating in Pharmaceuticals on the NSE and BSE.
Parnax Lab Ltd (506128) is a micro-cap Healthcare company valued at ₹155 crore operating in Pharmaceuticals on the NSE and BSE.
- Financial performance
- Revenue has been growing strongly at 13.9% a year over three years; profit grew 10.9% a year, behind revenue — margins are under pressure. Return on equity is 14.4%.
- Valuation multiples
- The stock trades at 13.4 times earnings, a discount to the Healthcare median of 32.5, 1.62 times book value.
Generated from DocStoX data. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Not currently trading — we have seen no trades on NSE or BSE recently. It may be suspended, delisted, or renamed after a corporate action. Not a live price.
DocStoX Score
6.3/10
Fair
Fair Value
Sign in to see
ROE
14.40%
Average
P/E
13.44x
Cheap
Debt / Equity
0.87
Moderate
Industry
Healthcare
Pharmaceuticals
Overall View
Fair
Price performance
52W₹108.03
₹144.95
DocStoX take
Supported by valuation (7.6) and growth (6.6), but weakest on risk (5.1). Scored on 4 of 5 measures.
DocStoX score
Medium confidence6.3
/10
Fair
Quality
Solid
ROE 14.4%
Valuation
Cheap
P/E 13.4×
Growth
Steady
Revenue +22.5% 5Y CAGR
Risk
Moderate
D/E 0.87
Momentum
No data
No technical indicators
Scored on 4 of 5 measures — the rest have no data for this company.
At a glance
Market Cap
₹155 Cr
52W High / Low
₹145 / ₹108
Dividend Yield
0.00%
Promoter Holding
72.30%
EPS (TTM)
₹10.03
Book Value
₹82.83
Key highlights
- Profitable in all of the last 5 years
- Undemanding at 13× earnings
- Revenue compounding 23% a year
- Small ₹155 cr company — thinner liquidity
3 Positives1 Watchout
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Pharmaceuticals
Explore Parnax Lab Ltd’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
Parnax Lab Ltd peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
Related tools & concepts
Value Parnax Lab Ltd with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing